In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
In the latest session, Hologic, Inc (NASDAQ: HOLX) closed at $61.82 up 1.83% from its previous closing price of $60.71. In other words, the price has increased by $1.83 from its previous closing price. On the day, 2.62 million shares were traded. HOLX stock price reached its highest trading level at $62.0 during the session, while it also had its lowest trading level at $60.52.
Ratios:
For a deeper understanding of Hologic, Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.03 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 12.27. For the most recent quarter (mrq), Quick Ratio is recorded 2.78 and its Current Ratio is at 3.49. In the meantime, Its Debt-to-Equity ratio is 0.53 whereas as Long-Term Debt/Eq ratio is at 0.52.
On February 06, 2025, Leerink Partners Downgraded its rating to Market Perform which previously was Outperform and also lowered its target price recommendation from $80 to $75.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 04 ’24 when Mitchell Essex D sold 24,856 shares for $76.34 per share. The transaction valued at 1,897,482 led to the insider holds 27,957 shares of the business.
Mitchell Essex D bought 24,856 shares of HOLX for $1,897,484 on Dec 04 ’24. On Aug 29 ’24, another insider, Oberton Karleen Marie, who serves as the Chief Financial Officer of the company, sold 52,679 shares for $80.56 each. As a result, the insider received 4,243,662 and left with 84,042 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HOLX now has a Market Capitalization of 13954196480 and an Enterprise Value of 14433765376. As of this moment, Hologic,’s Price-to-Earnings (P/E) ratio for their current fiscal year is 19.56, and their Forward P/E ratio for the next fiscal year is 13.31. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.51. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.43 while its Price-to-Book (P/B) ratio in mrq is 2.92. Its current Enterprise Value per Revenue stands at 3.574 whereas that against EBITDA is 11.284.
Stock Price History:
The Beta on a monthly basis for HOLX is 0.84, which has changed by -0.18988335 over the last 52 weeks, in comparison to a change of 0.09589827 over the same period for the S&P500. Over the past 52 weeks, HOLX has reached a high of $84.67, while it has fallen to a 52-week low of $60.33. The 50-Day Moving Average of the stock is -8.00%, while the 200-Day Moving Average is calculated to be -18.05%.
Shares Statistics:
For the past three months, HOLX has traded an average of 2.41M shares per day and 2403250 over the past ten days. A total of 225.56M shares are outstanding, with a floating share count of 222.47M. Insiders hold about 0.86% of the company’s shares, while institutions hold 103.13% stake in the company. Shares short for HOLX as of 1740700800 were 4440191 with a Short Ratio of 1.84, compared to 1738281600 on 5925073. Therefore, it implies a Short% of Shares Outstanding of 4440191 and a Short% of Float of 2.5999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
